2015
DOI: 10.1586/14737159.2015.1024660
|View full text |Cite
|
Sign up to set email alerts
|

Recent and near-future advances in nucleic acid-based diagnosis of stroke

Abstract: Stroke is a leading cause of death and disability in adults, but at present, treatment for ischemic stroke reaches only a small percentage of patients. This is because of the very short time window for treatment and the time-consuming evaluation involved. Intense efforts are underway to find novel approaches to expedite stroke diagnosis and treatment. In this review, we provide the rationale for the use of blood-based nucleic acid biomarkers to advance stroke diagnosis. We describe mRNA markers identified in g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 77 publications
0
5
0
Order By: Relevance
“…Because treatment of ischemic stroke must be done quickly, development of a rapid, inexpensive and accurate blood test would be valuable. Previous work aimed at developing a stroke blood test focused either on proteins or on coding mRNAs 6, 29, 40, 41 . The current findings that lncRNA are differentially expressed in stroke vs controls, and that expression of selected lncRNA change over time following ischemic stroke, could be considered in development of future biomarker panels to differentiate ischemic stroke from intracerebral hemorrhage and stroke mimics.…”
Section: Discussionmentioning
confidence: 99%
“…Because treatment of ischemic stroke must be done quickly, development of a rapid, inexpensive and accurate blood test would be valuable. Previous work aimed at developing a stroke blood test focused either on proteins or on coding mRNAs 6, 29, 40, 41 . The current findings that lncRNA are differentially expressed in stroke vs controls, and that expression of selected lncRNA change over time following ischemic stroke, could be considered in development of future biomarker panels to differentiate ischemic stroke from intracerebral hemorrhage and stroke mimics.…”
Section: Discussionmentioning
confidence: 99%
“…Here the rationale for the use of blood-based nucleic acid biomarkers to advance stroke diagnosis, treatment and prognosis determination was provided [ 19 , 20 ]. She described how stroke is a leading cause of death and disability in adults, but at present, treatment for ischemic stroke reaches only a small percentage of patients.…”
Section: Workhop Participant Presentationsmentioning
confidence: 99%
“…In this context, blood is a potentially dynamic tissue that reflects the physiological status of the animal [ 20 ]. Moreover, blood transcriptomic markers have been used to characterize vascular diseases [ 21 ], immune system responses [ 22 ], obesity status [ 23 ] and aging effects [ 24 ].…”
Section: Introductionmentioning
confidence: 99%